Friday, 17 Aug 2018

You are here

The RheumNow Week in Review – 28 July 2017

Dr. Jack Cush reviews the news and articles from the past week on RheumNow.com:

  1. Biologics makes for ~90% of cost of RA care - infusions cost/Yr RTX $36,663; TCZ $36,821, INFLX $4,973; ABA $46,532 https://t.co/HJNaVh4A5m
  2. EU/EMA follows FDA decision to approve Orencia (abatacept) for use in active psoriatic arthritis as mono or combo Rx https://t.co/RkxRsGKahQ
  3. NIH/NIAID phase I & II trial of MV-CHIKV, a recombinant, live-attenuated measles vax expressing chikungunya proteins https://t.co/UjAQelwz8r
  4. Retrospective study 1171 ANCA+ vasculitis shows 16% w/ inflamm ocular disease – Half with eye pain, 16% visuall loss: Scleritis 22% episcleritis 21%, Uveitis 9%  https://t.co/qqrXgaLkBf
  5. RCT shows ustekinumab or guselkumab does NOT significantly reduce the signs and symptoms of RA. https://t.co/14N8ZsKbZ3
  6. Discrepancy between ultrasound and DECT quantification of urate tophi in gout joints; lower sensitivity with DECT https://t.co/RL5Vkq6GSz
  7. Samsung Bioepis launches U.S. sales of Remicade biosmiliar- Renflexis https://t.co/emo6Te0yyW
  8. Biosimilar Pricing Wars Have Begun  
  9. Baricitinib Derailed by FDA Review
  10. Benlysta FDA Approved for Sub-Q Use in Lupus 
  11. Increased Pulmonary Embolism Risk in Lupus Patients  

 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – We’re Number One! (8.17.18)

Dr. Cush reviews the articles and news from the last week on RheumNow.com. Info on comorbidities, the down side of steroids, unmet need in psoriatic arthritis and the top 10 Rheumatology programs.

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on RheumNow.com. Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.

The RheumNow Week in Review – Lupus in the News (7.27.18)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.